Han-Qing Ye

ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 14

Top Venues

Signal transduction and targeted therapy

Virologica Sinica

PLoS pathogens

PLoS neglected tropical diseases

中国科学院武汉病毒研究所 (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

中国科学院武汉病毒研究所 Sep 01 2014 - Dec 01 2015

China

PHD

Publications

Hong-Qing Zhang, Ya-Nan Zhang, Zhe-Rui Zhang, Xiao-Ling Chen, Yan-Yan Hu, Yu-Jia Shi, Jing Wang, Cheng-Lin Deng, Bo Zhang, Xiao-Dan Li, Han-Qing Ye
An alphavirus replicon particle delivering prefusion-stabilized spike protein provides potent immunoprotection against SARS-CoV-2 Omicron variant. Signal transduction and targeted therapy 7 (1) (2022)
Hong-Qing Zhang, Ya-Nan Zhang, Zhe-Rui Zhang, Xiao-Ling Chen, Yan-Yan Hu, Yu-Jia Shi, Jing Wang, Cheng-Lin Deng, Bo Zhang, Xiao-Dan Li, Han-Qing Ye
An alphavirus replicon particle delivering prefusion-stabilized spike protein provides potent immunoprotection against SARS-CoV-2 Omicron variant. Signal transduction and targeted therapy 7 (1) (2022)
Hong-Qing Zhang, Ya-Nan Zhang, Zhe-Rui Zhang, Xiao-Ling Chen, Yan-Yan Hu, Yu-Jia Shi, Jing Wang, Cheng-Lin Deng, Bo Zhang, Xiao-Dan Li, Han-Qing Ye
An alphavirus replicon particle delivering prefusion-stabilized spike protein provides potent immunoprotection against SARS-CoV-2 Omicron variant. Signal transduction and targeted therapy 7 (1) (2022)
Zhe-Rui Zhang, Ya-Nan Zhang, Hong-Qing Zhang, Qiu-Yan Zhang, Na Li, Qi Li, Cheng-Lin Deng, Bo Zhang, Xiao-Dan Li, Han-Qing Ye
Berbamine hydrochloride potently inhibits SARS-CoV-2 infection by blocking S protein-mediated membrane fusion. PLoS neglected tropical diseases 16 (4) (2022)
Hong-Qing Zhang, Ya-Nan Zhang, Zhe-Rui Zhang, Xiao-Ling Chen, Yan-Yan Hu, Yu-Jia Shi, Jing Wang, Cheng-Lin Deng, Bo Zhang, Xiao-Dan Li, Han-Qing Ye
An alphavirus replicon particle delivering prefusion-stabilized spike protein provides potent immunoprotection against SARS-CoV-2 Omicron variant. Signal transduction and targeted therapy 7 (1) (2022)
Ya-Nan Zhang, Zhe-Rui Zhang, Hong-Qing Zhang, Xiao-Dan Li, Jia-Qi Li, Qiu-Yan Zhang, Jing Liu, Qi Li, Cheng-Lin Deng, Zheng-Li Shi, Zhi-Ming Yuan, Han-Qing Ye, Bo Zhang
Increased morbidity of obese mice infected with mouse-adapted SARS-CoV-2. Cell discovery 7 (1) (2021)
Ya-Nan Zhang, Na Li, Qiu-Yan Zhang, Jing Liu, Shun-Li Zhan, Lei Gao, Xiang-Yue Zeng, Fang Yu, Hong-Qing Zhang, Xiao-Dan Li, Cheng-Lin Deng, Pei-Yong Shi, Zhi-Ming Yuan, Shao-Peng Yuan, Han-Qing Ye, Bo Zhang
Rational design of West Nile virus vaccine through large replacement of 3' UTR with internal poly(A). EMBO molecular medicine 13 (9) (2021)
Jia-Qi Li, Zhe-Rui Zhang, Hong-Qing Zhang, Ya-Nan Zhang, Xiang-Yue Zeng, Qiu-Yan Zhang, Cheng-Lin Deng, Xiao-Dan Li, Bo Zhang, Han-Qing Ye
Intranasal delivery of replicating mRNA encoding neutralizing antibody against SARS-CoV-2 infection in mice. Signal transduction and targeted therapy 6 (1) (2021)
Na Li, Zhen Wang, Rui Wang, Zhe-Rui Zhang, Ya-Nan Zhang, Cheng-Lin Deng, Bo Zhang, Lu-Qing Shang, Han-Qing Ye
In Vitro Inhibition of Alphaviruses by Lycorine. Virologica Sinica (2021)
Ya-Nan Zhang, Si-Qing Liu, Cheng-Lin Deng, Zhi-Ming Yuan, Bo Zhang, Xiao-Dan Li, Han-Qing Ye
Development and Characterization of SYBR Green I Based RT-PCR Assay for Detection of Omsk Hemorrhagic Fever Virus. Virologica Sinica (2021)
Ya-Nan Zhang, Xiao-Dan Li, Zhe-Rui Zhang, Hong-Qing Zhang, Na Li, Jing Liu, Jia-Qi Li, Hua-Jun Zhang, Ze-Jun Wang, Shuo Shen, Zheng-Li Shi, Hong-Ping Wei, Zhi-Ming Yuan, Han-Qing Ye, Bo Zhang
A mouse model for SARS-CoV-2 infection by exogenous delivery of hACE2 using alphavirus replicon particles. Cell research 30 (11) (2020)
Jiqin Wu, Han-Qing Ye, Qiu-Yan Zhang, Guoliang Lu, Bo Zhang, Peng Gong
A conformation-based intra-molecular initiation factor identified in the flavivirus RNA-dependent RNA polymerase. PLoS pathogens 16 (5) (2020)
Na Li, Zhe-Rui Zhang, Ya-Nan Zhang, Jing Liu, Cheng-Lin Deng, Pei-Yong Shi, Zhi-Ming Yuan, Han-Qing Ye, Bo Zhang
A replication-defective Japanese encephalitis virus (JEV) vaccine candidate with NS1 deletion confers dual protection against JEV and West Nile virus in mice. NPJ vaccines 5 (1) (2020)
Zhe-Rui Zhang, Ya-Nan Zhang, Xiao-Dan Li, Hong-Qing Zhang, Shu-Qi Xiao, Fei Deng, Zhi-Ming Yuan, Han-Qing Ye, Bo Zhang
A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2. Signal transduction and targeted therapy 5 (1) (2020)

Han-Qing Ye.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Han-Qing Ye